EPRONTIA™已被批准作为单一疗法,用于治疗2岁及以上患者的部分发作或原发性全身强直-阵挛发作;作为辅助疗法,用...查看全文
美港电讯APP2021-08-06 16:28
$Eton Pharmaceuticals(ETON)$ 盘前涨10.4%,美国食品药品监督管理局(FDA)今日将审核是否批准Eton Pharmaceuticals治疗癫痫的口服新药。(来自美港电讯APP)查看全文
$Eton Pharmaceuticals(ETON)$ 内部交易: 2021-04-12,10% Owner,HARROW HEALTH, INC. ,卖出,1518000普通股, $7.00
$Eton Pharmaceuticals(ETON)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-21-008584 Size: 5 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001493152-21-008371 Act: 33 Size: 297 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-21-008273 Act: 34 Size: 208 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001493152-21-008195 Act: 33 Size: 300 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001493152-21-006265 Size: 2 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, items 5.02, 8.01, and 9.01 Accession Number: 0001493152-21-006262 Act: 34 Size: 39 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-21-006125 Act: 34 Size: 138 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-21-006122 Act: 34 Size: 5 MB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, item 8.01 Accession Number: 0001493152-21-004732 Act: 34 Size: 29 KB 网页链接